63 related articles for article (PubMed ID: 9058081)
1. Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs.
Abu-Zidan FM; Walther S; Lennquist S
Eur Surg Res; 1997; 29(2):133-41. PubMed ID: 9058081
[TBL] [Abstract][Full Text] [Related]
2. Role of platelet-activating factor antagonism in posthemorrhage septic shock in pigs.
Abu-Zidan FM; Walther S; Lennquist S
J Trauma; 1996 Oct; 41(4):634-40. PubMed ID: 8858021
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet-activating factor antagonism in haemorrhagic shock in pigs.
Abu-Zidan FM; Walther S; Lennquist S
Eur Surg Res; 1995; 27(6):379-88. PubMed ID: 8542923
[TBL] [Abstract][Full Text] [Related]
4. BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs.
Abu-Zidan FM; Walther S; Lennquist S
Pharmacol Toxicol; 1996 Jan; 78(1):23-7. PubMed ID: 8685082
[TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs.
Abu-Zidan FM; Walther S
Eur J Surg; 1996 Jun; 162(6):499-504. PubMed ID: 8817228
[TBL] [Abstract][Full Text] [Related]
6. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
Sagach VF; Dmitrieva AV; Braquet P
Lipids; 1991 Dec; 26(12):1400-3. PubMed ID: 1819740
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
[TBL] [Abstract][Full Text] [Related]
8. Modulation of lung injury by platelet-activating factor antagonism in nonhypotensive porcine endotoxemia.
Abu-Zidan FM; Walther S; Lennquist S
Circ Shock; 1994 Nov; 44(3):148-53. PubMed ID: 7600638
[TBL] [Abstract][Full Text] [Related]
9. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
Cunha-Goncalves D; Perez-de-Sa V; Grins E; Dahm PL; Thörne J; Blomquist S
Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
[TBL] [Abstract][Full Text] [Related]
10. [The role of the thrombocyte-activating factor in the development of circulatory disorders in the postischemic shock reaction].
Sagach VF; Dmitrieva AV
Fiziol Zh (1978); 1990; 36(4):8-14. PubMed ID: 2172032
[TBL] [Abstract][Full Text] [Related]
11. Myocardial ischemia in intestinal postischemic shock: the effect of hypoxemic reperfusion.
Douzinas EE; Pitaridis MT; Patsouris E; Kollias S; Boursinos V; Karmpaliotis DI; Gratsias Y; Evangelou E; Papalois A; Konstantinidou AE; Roussos C
Crit Care Med; 2003 Aug; 31(8):2183-9. PubMed ID: 12973178
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion.
Carter MB; Wilson MA; Wead WB; Garrison RN
J Surg Res; 1996 Feb; 60(2):403-8. PubMed ID: 8598677
[TBL] [Abstract][Full Text] [Related]
13. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Filep JG; Braquet P; Mózes T
Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
[TBL] [Abstract][Full Text] [Related]
14. Effect of a specific platelet-activating factor antagonist on cardiovascular and peripheral cellular responses to colonic ischemia and reperfusion in anesthetized ponies.
Wilson DV; Stick JA
Am J Vet Res; 1993 Mar; 54(3):443-8. PubMed ID: 8498751
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver].
Fukuoka T; Nakajima Y; Nakano H; Kenmochi T; Hayashi R; Suzuki S; Amemiya H
Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1474-80. PubMed ID: 1287460
[TBL] [Abstract][Full Text] [Related]
16. [An experimental study on shock after temporary hepatic inflow occlusion and platelet activating factor (PAF)].
Fukuoka T
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1596-602. PubMed ID: 2263243
[TBL] [Abstract][Full Text] [Related]
17. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
[TBL] [Abstract][Full Text] [Related]
19. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
Marzi I; Bauer M; Reisdorf E; Walcher F
Zentralbl Chir; 1994; 119(11):814-21. PubMed ID: 7846961
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
